Goodwill and In-process R&D
|3 Months Ended|
Mar. 31, 2021
|Goodwill and In-process R&D|
|Goodwill and In-process R&D||
7. Goodwill and In-Process R&D
Goodwill of $2.2 million and in-process R&D of $5.9 million were recorded in connection with the acquisition of Pelican, as described in Note 2. The Company performs an annual impairment test at the reporting unit level as of April 1st of each fiscal year. No impairment was recorded during the quarters ended March 31, 2021 or 2020.
The entire disclosure for goodwill and intangible assets.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef